Doppler ultrasonography and contrast-enhanced ultrasonography to evaluate liver allograft discard: A pilot

Hong-Jun Zhang1, Bo-Wen Zheng1, Shi-Jie Gu2

  • 1Department of Medical Ultrasonics, The Third Affiliated Hospital of Sun Yat-sen University, Guangdong Province Key Laboratory of Hepatology Research, Guangzhou, Guangdong, People's Republic of China.

Insights

Doppler ultrasonography (DUS) and contrast-enhanced ultrasonography (CEUS) can predict the discard risk of brain death (DBD) or cardiac death (DCD) donor livers. Prolonged hepatic artery systolic acceleration time (SAT) and decreased enhancement indicate higher discard probability.

Area of Science:

  • Transplant surgery
  • Medical imaging
  • Hepatology

Background:

  • Hemodynamic changes significantly impact donor liver viability after brain death (DBD) or cardiac death (DCD).
  • The utility of Doppler ultrasonography (DUS) and contrast-enhanced ultrasonography (CEUS) in assessing perfusion and predicting discard risk for these livers remains under investigation.

Purpose of the Study:

  • To evaluate the predictive capability of DUS and CEUS for the discard risk of DBD or DCD donor livers.

Main Methods:

  • Consecutive DBD or DCD donors underwent DUS/CEUS before organ procurement.
  • Analysis of DUS and CEUS images focused on recording specific perfusion parameters.

Main Results:

  • Fifteen out of 67 (22.4%) donor livers were discarded.
  • Discarded livers exhibited prolonged hepatic artery SAT on DUS (0.08s vs 0.06s) and reduced homogeneous enhancement on CEUS (40.0% vs 73.1%).
  • Multivariable analysis identified prolonged hepatic artery SAT and decreased enhancement as independent risk factors for liver discard.

Conclusions:

  • DUS and CEUS serve as promising tools for screening high-risk liver donors.
  • Prolonged hepatic artery SAT (DUS) and decreased liver enhancement (CEUS) reflect hemodynamic changes and are significant risk factors for discarding DBD/DCD donor livers.
Abstract